Dexcom INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

12 Feb 2026

DXCM

10-K: Dexcom Reports Strong 2025 Growth, New CGM Systems Drive Revenue

Dexcom, Inc. announced robust financial results for fiscal year 2025, driven by increased sales volume of its continuous glucose monitoring systems and the launch of new products like G7 15 Day and Stelo.

NASDAQ

14 Feb 2025

DXCM

Dexcom INC

10-K: Dexcom Reports 2024 Annual Results: Revenue Climbs to $4.03 Billion

Dexcom's 2024 annual report reveals an 11% increase in revenue, reaching $4.03 billion, driven by growth in continuous glucose monitoring systems.

NASDAQ

8 Feb 2024

DXCM

Dexcom INC

10-K: DexCom Outlines Share Structure and Corporate Governance in SEC Filing

DexCom's recent SEC filing details the company's capital stock, governance, and anti-takeover provisions, providing investors with a comprehensive overview of its structure.